RenovoRx Inc (RNXT US)

RenovoRx, Inc. operates as a clinical-stage biopharmaceutical company. The Company focuses on developing therapies for the local treatment of solid tumors and for targeted chemotherapy delivery for pancreatic cancer patients. RenovoRx serves customers in the United States.